Collectively our findings reveal, for the first time, the intriguing molecular mechanism of inactivation of the SMAR1 in higher grades of cancer, suggesting that the use of small molecules that can prevent SMAR1-Cdc20 interactions might be a good strategy for chemotherapy. The gene discussed is BANP; the disease is cancer.